Boostimmune
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Founded Year
2021Stage
Series A | AliveTotal Raised
$14.8MLast Raised
$13.06M | 2 mos agoAbout Boostimmune
Boostimmune researches and develops anticancer drugs that treat cancer by regulating the immune system. The company specializes in immuno-oncology drugs and antibody-drug conjugates that target myeloid. It was founded in 2021 and is based in Seoul, South Korea.
Boostimmune Headquarter Location
6F 36, Nambuhwan-ro 350-gil, Seocho-gu
Seoul,
South Korea
When was Boostimmune founded?
Boostimmune was founded in 2021.
Where is Boostimmune's headquarters?
Boostimmune's headquarters is located at 6F, Seoul.
What is Boostimmune's latest funding round?
Boostimmune's latest funding round is Series A.
How much did Boostimmune raise?
Boostimmune raised a total of $14.8M.
Who are the investors of Boostimmune?
Investors of Boostimmune include Smilegate Investment, Mirae Asset Financial Group, AJU IB Investment, Company K Partners, TIMEFOLIO Asset Management and 6 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.